KEY FEATURES
| Full Name | Fibrinopeptide A |
|---|---|
| Synonym | FP-A |
| Assay Type | Competitive |
| Reactivity | Human |
| Range | 1.56-100ng/mL |
| Sensitivity | 0.94ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 50μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human FPA in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with Human FPA. During the reaction, Human FPA in the sample or standard competes with a fixed amount of Human FPA on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Human FPA. Excess conjugate and unbound sample or standard are washed away, and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns from blue to yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of Human FPA in tested samples can be calculated by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human FPA ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 5.2 | 9.99 | 49.03 | 5.25 | 10.64 | 45.34 |
| Standard deviation | 0.33 | 0.51 | 1.86 | 0.36 | 0.59 | 1.88 |
| CV(%) | 6.39 | 5.14 | 3.8 | 6.89 | 5.53 | 4.14 |
RECOVERY
The recovery of Human FPA spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 89-103 | 95 |
| EDTA plasma (n=8) | 84-100 | 91 |
| Cell culture media (n=8) | 94-106 | 100 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human FPA in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with FPA ELISA Kits
| FGB ELISA Kit | publications with FPA and FGB |
| FGG ELISA Kit | publications with FPA and FGG |
| F13A1 ELISA Kit | publications with FPA and F13A1 |
| F13B ELISA Kit | publications with FPA and F13B |
| ITGA2B ELISA Kit | publications with FPA and ITGA2B |
| ITGB3 ELISA Kit | publications with FPA and ITGB3 |
| APOA1 ELISA Kit | publications with FPA and APOA1 |
Pathways associated with FPA ELISA Kit
| Amyloids Pathway | Amyloids Pathway |
| Blood Clotting Cascade Pathway | Blood Clotting Cascade Pathway |
| Common Pathway | Common Pathway |
| Complement And Coagulation Cascades Pathway | Complement And Coagulation Cascades Pathway |
| Disease Pathway | Disease Pathway |
| Extracellular Matrix Organization Pathway | Extracellular Matrix Organization Pathway |
| Formation Of Fibrin Clot (Clotting Cascade) Pathway | Formation Of Fibrin Clot (Clotting Cascade) Pathway |
| GRB2:SOS Provides Linkage To MAPK Signaling For Integrins Pathway | GRB2:SOS Provides Linkage To MAPK Signaling For Integrins Pathway |
| Hemostasis Pathway | Hemostasis Pathway |
Diseases associated with FPA ELISA Kit
| Afibrinogenemia | publications with FPA and Afibrinogenemia |
| Afibrinogenemia congenital | publications with FPA and Afibrinogenemia congenital |
| Cardiovascular Diseases | publications with FPA and Cardiovascular Diseases |
| Brain Diseases | publications with FPA and Brain Diseases |
| Thrombosis | publications with FPA and Thrombosis |
| Weight Gain | publications with FPA and Weight Gain |
| Hemorrhage | publications with FPA and Hemorrhage |
| Inflammation | publications with FPA and Inflammation |
| Hypertension | publications with FPA and Hypertension |
| Necrosis | publications with FPA and Necrosis |
Organs/Tissues associated with FPA ELISA Kit
| Blood | publications with FPA and Blood |
| Brain | publications with FPA and Brain |
| Liver | publications with FPA and Liver |
| Lung | publications with FPA and Lung |
| Heart | publications with FPA and Heart |
| Muscle | publications with FPA and Muscle |
| Kidney | publications with FPA and Kidney |
| Uterus | publications with FPA and Uterus |
| Embryonic Tissue | publications with FPA and Embryonic Tissue |
| Spleen | publications with FPA and Spleen |